Claims for Patent: 9,956,317

Summary for Patent: 9,956,317

Title:	Clinical applications of formulations containing adipose-derived stem cells
Abstract:	Methods and kits for producing cellular fractions enriched in adipose derived stem cells. Methods are provided where adipose tissue obtained from liposuction is enzymatically treated using a solution containing collagenase and divalent cations prior to the application of traditional methods of stromal-vascular fraction isolation. The enzymatic solutions may contain collagenase types I and II to a final concentration of about 0.001 mg/ml to 0.010 mg/ml. The divalent cations may be present as calcium, magnesium, and zinc chloride. The final concentration of calcium, magnesium, and zinc may range from about 0.001 to 0.1 micromolar; about 0.005 to 0.5 micromolar; and about 0.0015 to 0.15 micromolar, respectively. The enzymatic solutions may be generated using a kit where the collagenase and divalent components are held in separate containers until just prior to use. The cellular fractions isolated in this manner may be used in autologous fat grafts in therapeutic applications.
Inventor(s):	Rahimian; Shahram (Gainesville, FL)
Assignee:	Antria, Inc. (Indiana, PA)
Application Number:	15/131,441
Patent Claims:	1. A method of performing breast augmentation, comprising the steps of: isolating a cellular fraction enriched in adipose-derived stem cells, comprising the steps of: obtaining adipose tissue from a patient by aspiration; combining said adipose tissue with an enzymatic solution that includes collagenase and divalent cations including calcium at a concentration from about 0.001 to about 0.1 micromolar, zinc at a concentration from about 0.0015 to about 0.15 micromolar, and magnesium at a concentration of about 0.005 to about 0.05 micromolar; digesting said adipose tissue for a period of time sufficient to allow digestion of said adipose tissue; centrifuging the digested adipose tissue to form a centrifugate; and isolating a stromal vascular fraction from said centrifugate; mixing the stromal vascular fraction with a volume of adipose tissue obtained from the patient to form a fat graft; injecting the fat graft into breasts of the patient. 2. The method of claim 1, wherein said collagenase comprises collagenase type I and collagenase type II. 3. The method of claim 1, wherein said collagenase is present at a concentration from about 0.001 mg/ml to about 0.010 mg/ml. 4. The method of claim 1, wherein digesting step includes placing said adipose tissue and enzymatic solution mixture in an incubator. 5. The method of claim 1, further comprising the step of washing the stromal vascular fraction following said isolating step. 6. A method of improving wound healing, comprising the steps of: isolating a cellular fraction enriched in adipose-derived stem cells, comprising the steps of: obtaining adipose tissue from a patient by aspiration; combining said adipose tissue with an enzymatic solution that includes collagenase and divalent cations including calcium at a concentration from about 0.001 to about 0.1 micromolar, zinc at a concentration from about 0.0015 to about 0.15 micromolar, and magnesium at a concentration of about 0.005 to about 0.05 micromolar; digesting said adipose tissue for a period of time sufficient to allow digestion of said adipose tissue; centrifuging the digested adipose tissue to form a centrifugate; and isolating a stromal vascular fraction from said centrifugate; and administering the stromal vascular fraction to a wound on the patient. 7. The method of claim 6, wherein the administering step comprises applying the stromal vascular fraction around the wound site, into the wound, or under the wound. 8. The method of claim 6, wherein the administering step further comprises: combining the stromal vascular fraction to a wound dressing; and applying the wound dressing to the wound. 9. A method of treating osteoarthritic joint of a patient, comprising the steps of: isolating a cellular fraction enriched in adipose-derived stem cells, comprising the steps of: obtaining adipose tissue from the patient by aspiration; combining said adipose tissue with an enzymatic solution that includes collagenase and divalent cations including calcium at a concentration from about 0.001 to about 0.1 micromolar, zinc at a concentration from about 0.0015 to about 0.15 micromolar, and magnesium at a concentration of about 0.005 to about 0.05 micromolar; digesting said adipose tissue for a period of time sufficient to allow digestion of said adipose tissue; centrifuging the digested adipose tissue to form a centrifugate; and isolating a stromal vascular fraction from said centrifugate; and injecting the stromal vascular fraction into the osteoarthritic joint. 10. The method of claim 9, further comprising imaging said osteoarthritic joint during said injecting step.

Details for Patent 9,956,317

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2032-12-07